MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Cognitive Biases in Movement Disorders: Implications for Clinical Decision-Making and Patient Perception of Symptoms

    N. Choudhury, D. Buonadonna, B. Carr (Gainesvile, USA)

    Objective: To explore how cognitive biases affect decision-making in patients with movement disorders, including misjudgments in symptom perception, risk-taking in treatment decisions and adherence to…
  • 2025 International Congress

    The Clinical Case of Acute Comorbidities in Parkinson’s Disease

    P. Dynin, V. Yakovleva (Saint-Petersburg, Russian Federation)

    Objective: It may be difficult to distinguish the reason of previously described symptoms in case of acute comorbidities accompanying Parkinson’s diseaseThe 69 y.o. man was…
  • 2025 International Congress

    Pilot Feasibility Data using Augmented Reality and Machine Learning-Based Digital Cognitive Assessment in Parkinson’s disease

    K. Poplawska-Domaszewicz, A. Brek, K. Wu, N. Griffin, S. Fallone, M. Iulita, E. Streel, A. Kurta-Nowicka, K. Naskret-Gasik, J. Konczak, K. Ray Chaudhuri (Poznan, Poland)

    Objective: To assess the feasibility of using a novel cognitive and functional digital biomarker  assessment, the Altoida NeuroMarker platform, to evaluate the presence of MCI…
  • 2025 International Congress

    The Associations between Cognitive Reserve Proxies, Multimodal MRI Brain Measures and Cognition, Motor Function and Mood in Parkinson’s Disease

    I. Saywell, S. Sghirripa, A. Walls, A. Dwyer, B. Child, J. Salamon, S. Hansch-Maher, L. Collins-Praino, M. Jenkinson, I. Baetu (Adelaide, Australia)

    Objective: This study aimed to use multimodal MRI to explore the relative importance of cognitive reserve (CR) proxies, compared to CR- and Parkinson’s disease (PD)-related…
  • 2025 International Congress

    Correlation between Orthostatic Hypotension and Cognitive Impairment in Parkinson’s Disease

    M. Zhong, Y. Li, J. Liu (shanghai, China)

    Objective: This study aims to investigate the relationship between OH and cognitive impairment in PD patients using gray matter volume (GMV) analysis. Background: Orthostatic hypotension…
  • 2025 International Congress

    Hallucinations as a Distinguishing Neuropsychiatric Feature in Idiopathic Rapid Eye Movement Sleep Behavior Disorder Patients

    M. Trepanier Maurais, C. Zigrand, R. B. Postuma, J. Montplaisir, I. Rouleau, J. Gagnon (Montreal, Canada)

    Objective: This study aimed to assess the severity of neuropsychiatric symptoms in individuals with idiopathic/isolated rapid eye movement (REM) sleep behavior disorder (iRBD) according to…
  • 2025 International Congress

    Blood and CSF Biomarkers of Cognitive Impairment in Alpha Synucleinopathies

    C. Girges, N. Vijiaratnam, N. O’Reilly, J. Hay, V. Chelban, D. Athauda, H. Morris, H. Houlden, S. Gandhi, T. Foltynie (London, United Kingdom)

    Objective: The aim was to investigate the role of both well-established and novel protein biomarkers of cognitive impairment in Parkinson’s disease (PD) and multiple system…
  • 2025 International Congress

    The Cultural Validation of the Montreal Cognitive Assessment in Bangladeshi Adults with Parkinson’s Disease in East London

    K. Dey, A. Shahid, M. Singh, A. Zirra, E. Camboe, R. Weil, D. Gallagher, C. Budu, T. Haque, S. Waters, S. Ali, N. Mukadam, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: This study investigated the cultural validity of the Montreal Cognitive Assessment (MoCA) in Bangladeshi adults with Parkinson’s disease in East London using the validated…
  • 2025 International Congress

    Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors

    L. Ge, K. Asai, K. Ogawa, K. Ikenaka, Y. Kimura, H. Mochizuki (Suita, Japan)

    Objective: This study aims to identify predictors of cognitive decline in cognitively normal Parkinson’s disease patients by analyzing the 10 years-long PD registry. Background: Cognitive…
  • 2025 International Congress

    Subthalamic Deep Brain Stimulation Modulates Cognitive-Motor Integration in Parkinson’s Disease: Insights from a Dual-task fNIRS Study

    YQ. Zhang, JP. Li, Y. Liang (Beijing, China)

    Objective: To investigate the effects of STN-DBS on cognitive-motor dual-task performance in PD patients using an executive function-motor function dual-task paradigm combined with functional near-infrared…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley